Moreover, fisetin inhibits the release of proinflammatory cytokines by activated peripheral blood mononuclear cells (PBMCs) and keratinocytes (34), and the activation of PI3K/Akt/mTOR/MAPK in in vitro models of psoriasis (31, 34). Here, AKT1 is linked to psoriasis.